Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » OTCBB Reporting Stocks » SNDZ » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
luckylindy  - posted
SNDZ NEWS: PR Newswire and BusinessWire News
Sunridge International Inc SNDZ:OTC Bulletin Board Market
Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
PR Newswire
10:17 AM ET
Sunridge International (OTC Bulletin Board: SNDZ), an innovative developer of safe and noninvasive therapies for glaucoma, proudly announces its partnership with Luis Tiant and Scientific Social Solutions Charitable Foundation (S3) to provide medical relief in Cuba. Tiant, a Cuban native and former starting pitcher for the Boston Red Sox and New York Yankees, will work in conjunction with the Scientific Social Solutions Charitable Foundation and Ophthalmic International (www.oi-pnt.com), a wholly owned subsidiary of Sunridge, to help Cubans fight glaucoma.

Sunridge will send a medical team to Cuba to train doctors and treat patients, followed by a shipment of supplies to a distribution center to help patients after the team leaves the island. Glaucoma is the 2nd lea ding cause of blindness in Cuba, an issue Mr. Tiant will promote as the spokesperson for this charity drive.

Ophthalmic International has pioneered Pneumatic Trabeculoplasty (PNT), a two-minute, noninvasive, cost effective, alternative treatment for glaucoma. This treatment is ideal for Cuba and other countries' national health care systems because PNT is safe; and the treatment lasts 3-4 months before another round of care is necessary.

"I'm very excited about being a partner with Sunridge and Ophthalmic International in this medical relief program for Cuba. I know that glaucoma is an incredibly ser ious problem not only in Cuba but everywhere, and it is always good to be able to give something back," states Luis Tiant.

Credibility and Success Worldwide: Sunridge International in Action

Sunridge International continues to champion PNT and combat glaucoma. "We're extremely pleased with our involvement with Luis Tiant and this project. It will not only help the citizens of Cuba, but will most likely start a domino effect in the Caribbean, because of the fact that 'PNT' provides a safe, affordable and effective treatment for glaucoma patients everywhere," says G. Richard Smith, President and CEO of Sunridge International.

About Sunridge International

Headquartered in Fountain Hills, Arizona, Sunridge International (www.sunridgeint.com) is an innovative developer of Pneumatic Trabeculoplasty (PNT), a safe, noninvasive therapy for glaucoma. Through its wholly owned subsidiary, Ophthalmic International, the company manufactures a vacuum fixation device and a patented design suction ring for the treatment of open angle glaucoma.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

Contact: Jeff Smith, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International
 
luckylindy  - posted
SNDZ: a newly acquired wholly owned subsidiary Ophthalmic International (OI), is an innovative manufacturer of medical products. OI has developed and patented a 2-minute, non-invasive, cost effective, alternative treatment for glaucoma and ocular hypertension, known as Pneumatic Trabeculoplasty (PNT). OI holds worldwide patents on the PNT equipment, its disposable sterile suction ring, as well as the medical procedure itself. OI having secured 2a CE marketing approval throughout Europe and Canada is currently marketing its product line through an exclusive distributor network.

Glaucoma is the second leading cause of blindness, effecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects, unlike medications usually prescribed to treat glaucoma that come with a multitude of side effects.
 
luckylindy  - posted
SNDZ,a newly acquired wholly owned subsidiary Ophthalmic International (OI), is an innovative manufacturer of medical products. OI has developed and patented a 2-minute, non-invasive, cost effective, alternative treatment for glaucoma and ocular hypertension, known as Pneumatic Trabeculoplasty (PNT). OI holds worldwide patents on the PNT equipment, its disposable sterile suction ring, as well as the medical procedure itself. OI having secured 2a CE marketing approval throughout Europe and Canada is currently marketing its product line through an exclusive distributor network

Glaucoma is the second leading cause of blindness, effecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe and effective treatment with no adverse side effects, unlike medications usually prescribed to treat glaucoma that come with a multitude of side effects. For more information visit our website, http://www.oi-pnt.com/

Contact: Jeff Smith Phone: 602-363-6344 Email:
 
luckylindy  - posted
SNDZ: Over 67 Million people suffer from glaucoma worldwide. Over 63,000 new cases are diagnosed each year. If left untreated, glaucoma leads to

blindness.

PNT has been shown to reduce or even eliminate the need for additional drug therapies.

Approximately 50% of responders have their drug therapy eliminated, with the remaining 50% can have their medication reduced.
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share